Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant |
| gptkbp:activeIngredient |
gptkb:doxepin
|
| gptkbp:ATCCode |
gptkb:N06AA12
|
| gptkbp:CASNumber |
gptkb:1668-19-5
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adapin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Pfizer
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision weight gain drowsiness dry mouth |
| gptkbp:synonym |
gptkb:Sinequan
doxepin hydrochloride |
| gptkbp:usedFor |
gptkb:depression
anxiety |
| gptkbp:bfsParent |
gptkb:doxepin
gptkb:Doxepin |
| gptkbp:bfsLayer |
7
|